UNSPSC 51302503: Terbinafine hydrochloride

This classification denotes an antifungal agent with the molecular formula C21H25N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 012C11ZU6G, chemically known as n,6,6-trimethyl-n-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine but more generally known as terbinafine hydrochloride, which bears US NIH Compound Identifier 5402. European Medicines Agency schedules Terbinafine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04723MIG.

Most nations, for tariff and trade purposes, schedule terbinafine hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, TERBINAFINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Terbinafine hydrochloride bears US NLM identifiers UMLS ID C0771029 and NCI Concept Code C29492. SMILES: CC(C)(C)C#C/C=C/CN(C)CC1CCCC2C1CCCC2.CL.

UNSPSC 51302503 Terbinafine hydrochloride is a Commodity code for a specific pharmaceutical antifungal agent, yet the recent state and local solicitation activity tagged under this code does not reflect pharmaceutical procurement in the narrow sense. The City of Tampa Fire Rescue Department's ITB 25-P-00157, posted April 24, 2026, seeks a broad assortment of medical aid supplies including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets—a general first-aid and emergency medical inventory rather than terbinafine hydrochloride or other single-agent pharmaceuticals. The mismatch between the code's narrow pharmaceutical scope and the actual procurement activity suggests the code may be receiving miscategorized bids or that Tampa's procurement office applied a higher-tier pharmaceutical code. State and local governments buying under this code nominally purchase individual antifungal pharmaceutical products for health departments, correctional facilities, or emergency medical services, though the current record shows little activity aligned with that scope.

The City of Tampa is the sole issuing body present in recent records under this code. The ITB anticipates an initial one-year award period with two optional one-year renewals, with a total department budget of $100,000. The solicitation includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) offering a 5% bid discount capped at $10,000 and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) with discounts not to exceed $20,000. Bidders must submit electronically through the OpenGov eProcurement Portal, with the original bid opening scheduled for April 9, 2025 (note: the posted date of April 24, 2026 appears to reflect a reposted or amended solicitation). All medications must carry a minimum nine-month expiration date from acceptance, and the City reserves the right to award by aggregate total or individual line items.